Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=41337661&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
3-Deoxy-3beta-syringoylamino-betulinic acid Reduces Breast Tumor Growth and Lung Colonization, With Associated Downregulation of the RAS/RAF/MEK/ERK Pathway #MMPMID41337661
Liu H; Su PW; Song H; Wang C; Shan P; Zhang H
Chem Biodivers 2025[Dec]; ? (?): e02436 PMID41337661show ga
Betulinic acid (BA) and its structural derivatives/analogs exhibit diverse biological activities particularly antitumor property, which has established them as attractive research topics in recent years. In the present work, 33 3-substituted BA derivatives comprising 13 previously unreported ones were synthesized. Among them, a syringoyl analog (3-deoxy-3beta-syringoylamino-betulinic acid [DSABA]) showed significantly enhanced cytostatic activity against specific tumor cell lines. Further in vitro antitumor evaluation revealed that DSABA induced cell death and G(0)/G(1) phase arrest, as well as inhibited the migration and invasion, of two breast cancer cell lines, and the in vivo antitumor efficacy was subsequently validated in an orthotopic autograft mouse model. Mechanistically, DSABA may exert its antitumor effect by modulating the RAS/RAF/MEK/ERK signaling pathway, as evidenced by a series of in vitro and in vivo experiments. In conclusion, this study has identified DSABA as a promising antitumor candidate, providing a foundation for the future investigation of related structural analogs.
Chem+Biodivers 2025 ; ? (?): e02436
